Jian-Feng Yang

Engineering clinically actionable nanomedicine for cancer immunometabolic ecosystem reprogramming.

Traditional metabolic inhibitors have limited clinical efficacy, with issues such as narrow window periods, and compensatory effects. These barriers indicate that effective metabolic therapy requires spatially restricted, temporally coordinated, cell-context-aware, and clinically stratifiable intervention. This review...